HOME >> MEDICINE >> NEWS
Pioneering nanosystems degree wins approval

The Louisiana Board of Regents granted final approval Thursday for Louisiana Tech (in Ruston, La.) to offer a nanosystems engineering degree program, the nation's first such undergraduate degree.

Tech's new Bachelor of Science degree program will be implemented this fall.

According to the National Nanotechnology Initiative -- a federal coordinator of multi-agency efforts in nanoscale science, engineering and technology -- about 20,000 researchers are at work in nanotechnology today, and 2 million workers will be needed within 15 years to support nanotechnology industries worldwide.

"There's definitely a national need that we are responding to," said Dr. Stan Napper, dean of Tech's College of Engineering and Science.

He added that external resources are available to help fund nanotechnology programs, and NNI numbers bear him out.

Federal funding for nanotechnology research and development has increased from $116 million in 1997 to $961 million in 2004, according to the NNI, which also estimates that worldwide, government funding topped $2 billion in 2002.

"Government, and even more so industry, is funding the development of these applications," Napper said. "The funding is evidence of the capability and interest. As there is an increase in both the application of nanotechnology and of funding, there's a need for trained scientists and engineers."

Napper described nanosystems engineering as the application of basic chemistry and physics to analysis and design of devices and systems with nanoscale (one-billionth of a meter) features.

He said products already featuring nanoscale properties include cosmetics and stain-free clothing. In the near future, he said, expect advanced drug-delivery systems, medical diagnostic tools, and solar cells in roofing tiles and siding.

"Nanosystems are going to be useful in a wide variety of industries, not just so-called nanotechnology
'"/>

Contact: Darlene Bush Tucker
dtucker@latech.edu
318-257-4854
Louisiana Tech University
24-Feb-2005


Page: 1 2

Related medicine news :

1. Pioneering Welsh surgery delivered to hospitals
2. Pioneering treatments for irritable bowel syndrome, post traumatic stress disorder
3. Pioneering implants for deaf people
4. Lower degrees of social capital predict higher rates of sexually transmitted diseases
5. Nursing degree improves patient outcomes, study shows
6. New substance that improves the photodetection of bladder cancer gains market approval
7. NYUS Duster cautions against FDA approval of race-based pharmaceutical
8. US FDA grants full approval to DOXIL(R) following submission of phase III data
9. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pioneering nanosystems degree wins approval

(Date:5/23/2013)... FL (PRWEB) May 23, 2013 ... regenerative medicine company focused on the commercialization of ... and regeneration, today announced that the Company and ... million grant, for which AxoGen’s portion is approximately ... administrated by the U.S. Department of Defense (DoD) ...
(Date:5/23/2013)... 2013 Hile Design LLC is pleased ... awarded a Silver Creative Award at the Summit International ... entry was for its “Open Doors” animation promoting Scio ... in the 2013 District 6 ADDY Awards for the ... Creative Award recognizes and celebrates the creative achievements of ...
(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Registered ... R.D., published an article today on Tatalou.com offering helpful ... vacation. , The article, titled “ How to Stay ... important to carry hand sanitizer, when it’s safe to ... out for seafood, the importance of staying hydrated and ...
(Date:5/23/2013)... OH and Durham, NC (PRWEB) May 23, 2013 ... and commercialization firm that funds and develops innovative ... Deep Brain Innovations, LLC (DBI). DBI will ... optimize deep brain stimulation (DBS) therapy for patients ... is effective in treating Parkinson’s disease and generates ...
(Date:5/23/2013)... Consortium, Ltd., issued the following statement today on ... Reform of chemical safety legislation will succeed only ... Ensuring the safety and appropriate use of chemicals ... Toxic Substances Control Act is a critical opportunity ... transforming toxicity testing "from a system based on ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3Health News:How to Stay Healthy While Traveling 2Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3
(Date:5/22/2013)... PLAINS, N.Y. , May 22, 2013  The ... million to Valor Biotherapeutics, LLC, a joint ... of pre-clinical development, manufacturing, and a Phase I clinical ... the poor outcomes faced by many patients with indolent ... rituximab. Valor,s protein, IGN002, is a ...
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 ... presented from the DEFLECT-I study demonstrates that Keystone Heart,s ... volume during TAVR (Transcatheter Aortic Valve Replacement) procedures when ... Advisory Board announces consensus on the importance of preserving ... and need for cerebral protection during cardiovascular procedures to ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Is There Finally A Way To Stop Severe Excessive Sweating? 2
Cached News: